JDBAX
Price
$49.27
Change
-$0.38 (-0.77%)
Updated
Jun 17 closing price
Net Assets
28.26B
RLBFX
Price
$40.98
Change
+$0.34 (+0.84%)
Updated
Jun 18 closing price
Net Assets
287.61B
Interact to see
Advertisement

JDBAX vs RLBFX

JDBAX vs RLBFX Comparison Chart in %
View a ticker or compare two or three
VS
JDBAX vs. RLBFX commentary
Jun 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDBAX is a Hold and RLBFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 288B vs. JDBAX (28.3B). RLBFX pays higher dividends than JDBAX: RLBFX (2.02) vs JDBAX (1.52). JDBAX was incepted earlier than RLBFX: JDBAX (17 years) vs RLBFX (24 years). JDBAX (0.89) is less costly to investors than RLBFX (0.30). JDBAX is a more actively managed with annual turnover of: 75.00 vs. RLBFX (50.00). RLBFX has a lower initial minimum investment than JDBAX: RLBFX (250) vs JDBAX (2500). RLBFX annual gain was more profitable for investors over the last year : 16.27 vs. JDBAX (5.79). RLBFX return over 5 years is better than : 38.33 vs. JDBAX (22.53).
JDBAXRLBFXJDBAX / RLBFX
Total Expense Ratio0.890.30297%
Annual Report Gross Expense Ratio0.890.30297%
Fund Existence17 years24 years-
Gain YTD2.8968.97332%
Front Load6%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets28.3B288B10%
Annual Yield % from dividends1.522.0275%
Returns for 1 year5.7916.2736%
Returns for 3 years28.8343.4866%
Returns for 5 years22.5338.3359%
Returns for 10 years101.4891.15111%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFWGX18.01-0.18
-0.99%
MFS Global Total Return R1
ADRRX20.27-0.30
-1.46%
American Century Disciplined Growth R
NCEGX23.82-0.38
-1.57%
The North Country Large Cap Equity Fund
RRBGX186.88-2.98
-1.57%
T. Rowe Price Blue Chip Growth R
SMVLX92.72-1.66
-1.76%
Smead Value Investor